GlassScriptPhysician profile
Robin Pisor Mcbride
NPI 1912662735
$504.04
in general payments reported to CMS, 2019-2025
8 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $259 · 2024: $96.42 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $147.60 | 2023-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Bayer Healthcare Pharmaceuticals INC. | $121.83 | 2023 | |
| Olympus America INC. | $64.83 | 2023 | Spiration Valve System |
| Takeda Pharmaceuticals U.S.A., INC. | $45.82 | 2025 | Fruzaqla |
| Stemline Therapeutics INC. | $38.60 | 2025 | Orserdu |
| Geron Corporation | $34.44 | 2025 | Rytelo |
| Adc Therapeutics America, INC. | $29.47 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.45 | 2023 | Tagrisso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.